Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Inoperable Non Small Cell Lung Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00016315
What this trial is testing

Gemcitabine, Carboplatin or Paclitaxel Plus Radiation Therapy in Treating Patients With Stage IIIA or IIIB Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Radiation Therapy Oncology Group 35
Early research (Phase 1)Active Not RecruitingNCT04505267
What this trial is testing

NBTXR3 and Radiation Therapy for the Treatment of Inoperable Recurrent Non-small Cell Lung Cancer

Who this might be right for
Recurrent Lung Non-Small Cell CarcinomaStage I Lung Cancer AJCC v8Stage IA1 Lung Cancer AJCC v8+11 more
M.D. Anderson Cancer Center 34
Testing effectiveness (Phase 2)Active Not RecruitingNCT00334815
What this trial is testing

Combination Chemotherapy, Radiation Therapy, and Bevacizumab in Treating Patients With Newly Diagnosed Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery

Who this might be right for
Lung AdenocarcinomaLung Adenosquamous CarcinomaLung Large Cell Carcinoma+4 more
National Cancer Institute (NCI) 29
Testing effectiveness (Phase 2)UnknownNCT00697333
What this trial is testing

Radiotherapy Planning Based on Positron Emission Tomography With Fluoro-deoxyglucose For Advanced NSCLC

Who this might be right for
Non-small Cell Lung Cancer
Arbeitsgemeinschaft Nuklearmedizin und Strahlentherapie der DEGRO und DGN 200
Testing effectiveness (Phase 2)Ended earlyNCT03148327
What this trial is testing

Astra Zeneca (Immuno Stereotactic Ablative Body Radiotherapy) ISABR Study: Randomized Phase I/II Study of Stereotactic Body Radiotherapy

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Jonsson Comprehensive Cancer Center 18
Not applicableStudy completedNCT02131259
What this trial is testing

Long-term Observation PMS for Afatinib

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Boehringer Ingelheim 1,605
Testing effectiveness (Phase 2)Study completedNCT01368848
What this trial is testing

Combination of Cisplatin, Docetaxel and Bevacizumab in Patients With Non-small Cell Lung Carcinoma (NSCLC)

Who this might be right for
NSCLC
Arbeitsgemeinschaft medikamentoese Tumortherapie 7
Large-scale testing (Phase 3)UnknownNCT00989690
What this trial is testing

Study of Blood and Tissue Samples in Predicting Response to Second-Line Therapy Using Erlotinib Hydrochloride or Chemotherapy in Patients With Advanced Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Istituto Scientifico H. San Raffaele 275
Testing effectiveness (Phase 2)Study completedNCT02473133
What this trial is testing

Study of Interest of Personalized Radiotherapy Dose Redistribution in Patients With Stage III NSCLC

Who this might be right for
Non-small Cell Lung Cancer
Centre Henri Becquerel 158
Not applicableStudy completedNCT01951755
What this trial is testing

Phase IV Study of Tarceva in Patients With Advanced Stage IIIB/ IV Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-small Cell Lung Cancer
University of Athens 150
Early research (Phase 1)UnknownNCT00006212
What this trial is testing

Phosphorus-32 Plus Radiation Therapy and Chemotherapy in Treating Patients With Stage II or Stage III Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
Center for Molecular Medicine
Testing effectiveness (Phase 2)Study completedNCT00200395
What this trial is testing

OSI-774 (Erlotinib, Tarceva) in Elderly Patients

Who this might be right for
Non-Small Cell Lung Cancer
Montefiore Medical Center 30
Early research (Phase 1)Study completedNCT01899989
What this trial is testing

Stereotactic Body Radiation Therapy for Inoperable Locally-advanced Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Memorial Sloan Kettering Cancer Center 39
Very early researchEnded earlyNCT01525446
What this trial is testing

Proton Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Massachusetts General Hospital 7
Early research (Phase 1)Ended earlyNCT00692380
What this trial is testing

Gated Intensity Modulated Radiation Therapy and Concurrent Chemotherapy for Inoperable NSCLC

Who this might be right for
Non-small Cell Lung Cancer
Virginia Commonwealth University 28
Testing effectiveness (Phase 2)Study completedNCT00400803
What this trial is testing

Carboplatin and Gemcitabine With Bevacizumab Every 2 Weeks for Stage IIIb/IV Non-small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Masonic Cancer Center, University of Minnesota 38
Not applicableActive Not RecruitingNCT05887011
What this trial is testing

CRT( Chemo-Radiation Therapy) Patterns and Short-term Outcomes on Unresectable NSCLC and SCLC in Routine Practices in Russia

Who this might be right for
Unresectable /Inoperable Locally Advanced (Stage II-III) NSCLC and Locally Advanced LS-SCLC (Stage I-III)
AstraZeneca 2,000
Early research (Phase 1)Active Not RecruitingNCT04676477
What this trial is testing

HER3-DXd (Patritumab Deruxtecan; U3-1402) in Combination With Osimertinib in Subjects With Locally Advanced or Metastatic EGFR-mutated Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer (NSCLC)
Daiichi Sankyo 246
Not applicableStudy completedNCT03911219
What this trial is testing

Impact of eHealth Monitoring on Overall Survival in Patients With Metastatic NSCLC / Extensive-stage SCLC / Advanced TNBC Under First-line Treatment With Atezolizumab Plus Chemotherapy

Who this might be right for
Stage IV Non-small Cell Lung CancerExtensive-stage Small Cell Lung CancerAdvanced (Locally Advanced and Inoperable or Metastatic), PD-L1 IC-positive TNBC
iOMEDICO AG 154
Large-scale testing (Phase 3)Study completedNCT01968941
What this trial is testing

Stereotactic Body Radiotherapy Versus Conventional Radiotherapy in Medically-Inoperable Non-Small Lung Cancer Patients

Who this might be right for
Non-small Cell Lung Cancer
Ontario Clinical Oncology Group (OCOG) 324
Next Page